Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?

被引:0
|
作者
Francisco José Tarazona-Santabalbina
Luis Aguilella-Fernández
机构
[1] Hospital Universitario de la Ribera,Geriatric Medicine Deparment
[2] Hospital Universitario de la Ribera,Orthopaedics Department
关键词
Hip fracture; Bisphosphonates; Long-term treatment;
D O I
暂无
中图分类号
学科分类号
摘要
Long-term treatment with biphosphonates has been related to atypical femoral fractures. We report the clinical case of a woman who suffered a proximal diaphyseal oblique fracture of the left femur after uninterrupted 13-year treatment with alendronate. Shortly after surgery, a painful lytic image in the external cortex of her right femur diaphysis was detected. Some papers have suggested surgical treatment to repair femur fractures after long-term treatment with bisphosphonates. Otherwise, two studies have shown healing acceleration of bone fractures with teriparatide. A lytic lesion was treated with teriparatide obtaining progressive disappearance of symptoms as well as bone healing. This outcome may suggest a way of prevention of complete fractures in symptomatic patients with long-term treatment with bisphosphonates.
引用
收藏
页码:605 / 609
页数:4
相关论文
共 50 条
  • [31] Atypical bilateral femoral fractures: a rare adverse effect of long-term bisphosphonate use
    Onafowokan, Oluwatobi O.
    BMJ CASE REPORTS, 2021, 14 (09)
  • [32] Is severely suppressed bone turnover in patients on long term bisphosphonate treatment causally related atypical femoral fracture?
    Qiu, Shijing
    Divine, George
    Warner, Elizabeth
    Rao, Sudhaker
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 113 - 113
  • [33] Surgical treatment of bilateral femoral stress fractures related with long-term alendronate therapy
    Kanatli, Ulunay
    Ataoglu, M. Baybars
    Ozer, Mustafa
    Topcu, H. Nevzat
    Cetinkaya, Mehmet
    EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY, 2017, 28 (01): : 55 - 58
  • [34] Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: A pictorial review
    Venkatanarasimha N.
    Miles G.
    Suresh P.
    Emergency Radiology, 2010, 17 (6) : 511 - 515
  • [35] Long-term bisphosphonate usage and subtrochanteric insufficiency fractures A CAUSE FOR CONCERN?
    Yoon, R. S.
    Hwang, J. S.
    Beebe, K. S.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2011, 93B (10): : 1289 - 1295
  • [36] Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?
    Koh, Joyce S. B.
    Goh, Seo Kiat
    Png, Meng Ai
    Kwek, Ernest B. K.
    Sen Howe, Tet
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2010, 24 (02) : 75 - 81
  • [37] A Case Report of Long-Term Bisphosphonate Therapy and Atypical Stress Fracture of Bilateral Femur
    Jo, Yil Ryun
    Kim, Hye Won
    Moon, Seock Ho
    Ko, Young Jin
    ANNALS OF REHABILITATION MEDICINE-ARM, 2013, 37 (03): : 430 - 432
  • [38] Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report
    Y. Asano
    K. Tajiri
    S. Yagishita
    H. Nakanishi
    T. Ishii
    Osteoporosis International, 2020, 31 : 2473 - 2476
  • [39] Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report
    J.-T. Kim
    Y.-H. Cha
    S. Jeong
    J.-I. Yoo
    C.H. Park
    Osteoporosis International, 2021, 32 : 2115 - 2118
  • [40] Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report
    Kim, J. -T.
    Cha, Y. -H.
    Jeong, S.
    Yoo, J. -I.
    Park, C. H.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (10) : 2115 - 2118